Skye Bioscience

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SKYE and other ETFs, options, and stocks.

About SKYE

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion.

CEO

Punit S. Dhillon

CEOPunit S. Dhillon

Employees

Employees16

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2011

Founded2011

Employees

Employees16

SKYE Key Statistics

Market cap

51.12M

Market cap51.12M

Price-Earnings ratio

-1.61

Price-Earnings ratio-1.61

Dividend yield

—

Dividend yield—

Average volume

2.90M

Average volume2.90M

High today

$1.76

High today$1.76

Low today

$1.64

Low today$1.64

Open price

$1.72

Open price$1.72

Volume

631.76K

Volume631.76K

52 Week high

$5.96

52 Week high$5.96

52 Week low

$1.14

52 Week low$1.14

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own SKYE. This list is generated using Robinhood data, and it’s not a recommendation.